Neoantigen-Targeted ppDC Vaccine(Uclas Jonsson Comprehensive Cancer Center)

N/A

Report date: 2024/04/12 20:03:58

Base Information

Drug NameNeoantigen-Targeted ppDC Vaccine(Uclas Jonsson Comprehensive Cancer Center)
Drug Alias NameNeoantigen-Targeted Dendritic Cell Vaccine(Uclas Jonsson Comprehensive Cancer Center)Dendritic Cell Vaccine Therapy(Uclas Jonsson Comprehensive Cancer Center)
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUclas Jonsson Comprehensive Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesUclas Jonsson Comprehensive Cancer Center
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A